chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 36 hours after vaccine I felt soreness on my scalp.  Within 48 hours I had a breakout of blisters high on my left side forehead and onto my scalp.  These bumps/blisters ran only on the left side of my head back almost to the middle of my head.  The blisters itched some, then my scalp tingled and I felt sharp pains occasionally.   The bumps on my scalp turned red and later scabs formed.  After 3 days the worst feeling/pain abated.  It took 10 days for all scabs to disappear.
PATIENT CALLED TO REPORT THAT SHE EXPERIENCED TINGLING  AND FEELING OF NUMBNESS IN JAW AND  ARM ABOUT 2 HOURS AFTER THE VACCINE FOR ABOUT 30 - 40 MIN
Swelling in hands, joints, causing a weak grasp and general aching, continued symptoms.
My left arm has been painful the past 3 months since my second shot. After 2ns shot it took me 4 days to recover. Fever body aches headaches and soar arm (which never went away). Randomly it gets a numb pain as if I just got a shot in that arm. It usually takes 10-15mins for the pain to dim down (The best way to describe it is as if my arm fell asleep the way someone?s leg may fall asleep from sitting on it)
Pt developed stuffy nose, malaise, and productive cough of clear secretions.  Developed a light pink, itchy rash on left leg. Recommended topical OTC hydrocortisone 1% cream or ointment for rash.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about "December or 01-JAN-2009", the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 01-APR-2016, the patient was treated by a physician for a blistering vesicular outbreak and decreased immune symptoms which was then diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
25APR91 gave MMR/HIB; 1 wk p/immun developed fever (low grade) for 3 days then OK; on 15MAY91 fever, put on Amoxicillin did not help fever as high as 104/105, 21MAY91; MD then placed on Pediazol on 22MAY91 103 & slowly reducing;
The vial was initially stored in the refrigerator on 16-Mar-2023.; No adverse event; expired dose was given to an 8 years old patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose was given to an 8 years old patient), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 16-Mar-2023.) and NO ADVERSE EVENT (No adverse event) in an 8-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019C22A) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 06-Apr-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose was given to an 8 years old patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 16-Mar-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose was given to an 8 years old patient), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 16-Mar-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (expired dose was given to an 8 years old patient) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 16-Mar-2023.).    No concomitant medications were reported.  It was reported that an expired dose of Monovalent vaccine was given to an 8 year old patient in a mobile clinic. Vial size was reported as 2.5 ml.  The vial was initially stored in the refrigerator on 16-Mar-2023. The vial did not undergo any temperature excursions. No treatment details were reported.
Dizziness; Minor pain at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 07Apr2021 at 09:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications were not reported. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 07Apr2021 at 10:15, the patient experienced dizziness that started about 30 minutes after the injection and minor pain at the injection site. The patient reported that the dizziness peaked about 2 hours after the injection and had slowly diminished over the past 5 hours. At this time of this report the patient still experienced dizziness and also the minor pain at the injection site had also slowly diminished. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event dizziness and injection site pain (vaccination site pain) was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Light headedness; Wheezing; Headache; Migraine; Weakness; Fatigue; Fever for 3 days.; This is a spontaneous report from a non-contactable reporter (healthcare professional). The reporter is the patient.   An adult female patient (not pregnant) received bnt162b2 (BNT162B2) (Lot number: unknown) as dose 1, single and bnt162b2 (BNT162B2) (Lot number: unknown) as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Penicillin allergy" (unspecified if ongoing), notes: Known allergies: Penicillin. Concomitant medications were not reported.   The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Light headedness"; WHEEZING (non-serious), outcome "unknown", described as "Wheezing"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; MIGRAINE (non-serious), outcome "unknown", described as "Migraine"; ASTHENIA (non-serious), outcome "unknown", described as "Weakness"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue"; PYREXIA (non-serious), outcome "unknown", described as "Fever for 3 days".   Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Parent (father) reported that child of parent reported awaken on 8-2-11 with s/s noted swelling at right arm site. C/o soreness and noticeable tender to touch. Denies fever, respiratory problems, or other problems. Advised post care & immobilization, ice pack, pain reducer acetaminophen or ibuprofen as directed.
Varicella-Flu-like symptoms beginning 8/11, Tmax 102, 8/14 Diffuse pruritic papular vesicular rash c/w varicella. Treated with VALTREX x 5 day, CXR (-), fatigue and rash resolved over 2 weeks.
Information has been received from a 26 year old female patient with no drug reactions or allergies and no pertinent medical history who on 10-JAN-2011 was vaccinated with PROQUAD by one of the immunization specialists in the physician's office. The patient had been getting a series of vaccinations but had been getting MMR II and VARIVAX (Merck) separately but at the same time. Concomitant therapy included LEXAPRO. The patient said that on 01-JAN-2011, he had some itching and minor pain at the injection site, but no other issue. There was no treatment given to the adverse event. There were no laboratory diagnostics studies performed. The office just called her to say that she received a vaccine that was not approved for her age group. At the time of the reporting, the patient's outcome was unknown. The patient did not seek medical attention. No further information is available.
Patient stated that she was having neck soreness, feeling warm with chills, soar throat with hot eyes
Vertigo (days 2-4), headache (days 2-3) and nausea (days 2-4).
Narrative:  90yo patient in home hospice care died at home on 11/12/2021. Pt's Hospice Diagnoses: Cerebral Infarction w/ hx of CAD. Pt had received covid vaccines on 5/26/21 & 6/16/21. Death is not related to covid vaccines.
fever; fatigue; malaise; This case was reported by a consumer via call center representative and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, fatigue and malaise. On an unknown date, the outcome of the fever, fatigue and malaise were recovered/resolved.   It was unknown if the reporter considered the fever, fatigue and malaise to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's friend. The age at vaccination was not reported. The reporter stated that the patient is in his 60's. The patient received Shingrix on an unknown arm.  The patient developed fever, fatigue, and malaise that lasted approximately 2 to 3 days. The reporter did not provide any additional information.  This case has been linked with the case US2019AMR113702, reported by same reporter for the same patient.
It was reported that a pt (2 of 7) received Fluzone 98-99 between 10/3/98 and 10/6/98. Reportedly the pt experienced vomiting and diarrhea.
Per mom on December 20th 2009 at noon patient started having vomiting and diarrhea, No fever, mom gave pedialyte symptoms resolved on 12/21/2009.
received a dose of Bexsero instead of Menactra; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA81EZ, expiry date 31st January 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 30th April 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 30th April 2021, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter stated that, the patient received a dose of Bexsero instead of Menactra, which led wrong vaccine administered. The reporter consented to follow up.
4 hrs /p injection DPT .25 cc child woke up crying, parents noted child pale & blue around mouth, extremities were twitching, in route to MD ofc. childs head went limp.
Employee states the pain in her back near her (L) shoulder blade begin the very next morning after receiving a flu shot in her (L) arm. She takes OTC EXCEDRIN, but states it's only minor relief. She has not seen a physician for the pain/discomfort as of 11/8/11. She reports feeling a knot in her back.
felt like I might pass out /dizzy; brain fog/hard time thinking; tightness of chest and throat; difficulty swallowing; hard time thinking and talking normal; hard time thinking and talking normal; This is a spontaneous report from a contactable consumer (patient)   A 42-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: en9815) on 11Feb2021 at 15:45 at single dose via an unspecified route of administration on right arm for COVID-19 immunization. Relevant medical history included congenital adrenal hyperplasia and slight lactose intolerance. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), prednisone and naphazoline hydrochloride (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]). On 11Feb2021 patient experienced dizzy, felt like she was to pass out, brain fog/hard time thinking and talking normal, tightness of chest and throat, difficulty swallowing. Events resulted in visit to emergency room.  The latter 2 events continued to get worse so they gave the patient an epinephrine injection (reported as EPI shot). Benadryl IV was also administered. At the time of the reporting the patient was recovering from reported events.
Unable to get second dose; physiologic arthritic flare; Physiologic arthritic flare; High Temperature; Small patches of pneumonia (pleuritis); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PNEUMONIA (Small patches of pneumonia (pleuritis)) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D1DM20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included PREDNISONE for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PNEUMONIA (Small patches of pneumonia (pleuritis)) (seriousness criterion medically significant), ARTHRITIS (physiologic arthritic flare), ARTHRALGIA (Physiologic arthritic flare) and PYREXIA (High Temperature). On 10-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Unable to get second dose). On 10-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Unable to get second dose) had resolved. At the time of the report, PNEUMONIA (Small patches of pneumonia (pleuritis)), ARTHRITIS (physiologic arthritic flare), ARTHRALGIA (Physiologic arthritic flare) and PYREXIA (High Temperature) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.  Based on the current available information and the Temporal association between the use of the product and start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the Temporal association between the use of the product and start date of the events a causal relationship cannot be excluded.
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient fainted after receiving injection. Unresponsive for 1-2 seconds and then awoke. Reports feeling "very hot" then began shivering; EMTs called and onsite within 10 minutes. Patient refused further care/hospital evaluation
?Moderna COVID-19 Vaccine   After leaving the vaccine clinic I noticed my lower lip becoming slightly tingly but never swelling. The same with the tip of my tongue, tingly but never swelling.
Patient accidentally received a second MENACTRA vaccination with no reported adverse event; Initial information received on 30-Nov-2021 regarding an unsolicited valid non-serious case from an other health professional via Media Information (under reference 00878903).  This case involves a 17 years old female patient who accidentally received a second dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (extra dose administered).  The patient had previously received a Menveo vaccine in 2016.   The patient's other medical history, medical treatment(s) and family history were not provided.  The patient received dose of HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL), dose of DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, TETANUS VACCINE TOXOID (BOOSTRIX) and dose of HEPATITIS A VACCINE INACT (HAVRIX) [Lot and expiration date were not reported] via unknown route in an unknown administration site for prophylactic vaccination as concomitant vaccines..  On 16-Oct-2020, the patient received first dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number and expiration date were not reported) via unknown route in unknown administration site for prophylactic vaccination.   On 29-Nov-2021, she also received 0.5 mL second dose of the same vaccine (Total, lot U7191AA and expiration date: 18-Jan-2023) via intramuscular route in the right deltoid for prophylactic vaccination.  It was a case of an actual medication error due to Extra dose administered (same day latency).  At time of reporting, no adverse event reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Lab Notes:Nasal Swab  /Result:Positive; Lab Notes:Nasal Swab  /Result:Positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Mar2021 at 15:00 as dose 1, single (Lot number: EP7534), in left arm, on 10Apr2021 at 15:00 as dose 2, single (Lot number: EN5318), in left arm and on 27Nov2021 at 16:30 as dose 3 (booster), single (Lot number: FJ1620) at the age of 53 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "HSV2" (unspecified if ongoing); "Hashimotos" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing); "herniated discs" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "Known allergies: Eggs, Hazelnuts, lactose" (unspecified if ongoing). Concomitant medication(s) included: B12-VITAMIIN; D3; LIVALO; OMEPRAZOLE; VALACYCLOVIR [VALACICLOVIR]; SYNTHROID. Past drug history included: Amoxicillin, reaction(s): "known allergies: Amoxicillin"; Ibuprofen, reaction(s): "Known allergies: Ibuprofen". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 01Feb2022, outcome "unknown" and all described as "Lab Notes:Nasal Swab  /Result:Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18Apr2021) Negative, notes: Nasal Swab; (13May2021) Negative, notes: Nasal Swab; (03Aug2021) Negative, notes: Nasal Swab; (01Feb2022) Positive, notes: Nasal Swab; SARS-CoV-2 RNA: (18Apr2021) Negative, notes: Nasal Swab; (13May2021) Negative, notes: Nasal Swab; (03Aug2021) Negative, notes: Nasal Swab; (01Feb2022) Positive, notes: Nasal Swab. Clinical course: Patient had no other vaccine in four weeks and Covid prior vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300252940 same reporter/patient/product, different dose/event;US-PFIZER INC-202300253096 same reporter/patient/product, different dose/event;US-PFIZER INC-2021367791 same reporter/patient/product, different dose/event;
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Cellulitis-Medium.
Patient became faint & pale approx 10 min. after the GARDASIL was administered. Pt. was sitting up & was positioned laying down with pillow elevating her legs. V.S.: SPO2 92 P - 76 B/P 110/50. 9:55 vital sign: P - 74, SPO2 - 98 BP 100/60 alert & responsive & talking.
5pm felt warm, temp at 99.3. clingy behavior. Gave one advil, settled down. Advil relieved his behavior. Ate dinner, off balance afterwards,  fell asleep..possible seizure activity occurred 6pm. I increased his klonopin by .5mg.  To monitor.
Pt. received vaccine on 10/25/2022. Documentation reports left deltoid, but pt is reporting he received vaccine in his right deltoid. Pt. specifically reports that he received a TDAP vaccine in his left deltoid 2 weeks prior to his COVID vaccine and requested it to be in his left deltoid, but nurse reported she would like to do the vaccine in the right deltoid.  Pt reports he had discomfort immediately, but approx. 1 week later, he noticed a bruise on his right arm below the area the shot given. Denies any injury. Approx 2 weeks later, he noticed "red bumps that are very tender" that have gotten worse. Reports he noticed only 2 bumps, but now has approx. 10.  Pt states "they are painful and have a tingly feeling." Denies any trouble breathing or rashes anywhere else on the body.
Patient complained that she's been losing her hairs a lot since 2nd pfizer shot.   She does not use shampoo when she never use any shampoo
about 10-15 minutes after injection, felt tightness in throat and sore throat with a little difficulty breathing.  Notified onsite RN who immediately gave him 50mg oral Benadryl. Vitals done by EMT onsite, BP `164/108, P=110, slightly swollen tongue.  Did not have Pulse Oximeter until 30m after reaction. At that time, O2=94%. 15m after Benadryl patient stated he felt 80% better. 45m after Benadryl patient felt 95% better, BP = 134/96, P= 64, O2=98% and no tongue swelling. Patient wife will pick him up and drive him home. Instructed to take 50mg in 4 hours and call 911 if any symptoms return.
Patient reported mouth, tongue and throat feeling tingling and numb. No reports of trouble breathing. Patient's mouth  or lips did not appear to be swollen upon visual inspection. Patient was given Benadryl 50mg PO, without any improvement in the patient's symptoms (per patient report).
24 hrs. after receiving the 2nd dose, I had pain on moth wrists. Eight at the top where the wrist comes together. It was like I could put my finger on the pain points. When that went away after a day or two, I began getting stiffness in my hands and feet. It was mostly at night. I did have an episode where I went to get out of a chair and I felt discoordinated walking. The ankle and foot pain and stiffness has gone away. I still have an intermittent hand stiffness. It will sometimes wake me up at night and is usually there in the morning. It usually lasts half an hour. Opening things is harder for me now, this was not an issue I had prior. I do not experience the joint pain while opening jars but it is still difficult for me. I have been taking B12 supplements for a few weeks now.